These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 21749268)

  • 1. Once daily controlled release matrix tablet of Prochlorperazine maleate: influence of Ethocel® and/or Methocel® on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Shah NH; Bukhari NI; Saeed M; Shah KU
    Drug Dev Ind Pharm; 2012 Feb; 38(2):190-9. PubMed ID: 21749268
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of controlled-release matrix tablet of risperidone: influence of Methocel®- and Ethocel®-based novel polymeric blend on in vitro drug release and bioavailability.
    Badshah A; Subhan F; Rauf K; Bukhari NI; Shah K; Khan S; Ahmed Z; Khan I
    AAPS PharmSciTech; 2011 Jun; 12(2):525-33. PubMed ID: 21494924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Controlled release matrix tablets of olanzapine: influence of polymers on the in vitro release and bioavailability.
    Badshah A; Subhan F; Rauf K
    AAPS PharmSciTech; 2010 Sep; 11(3):1397-404. PubMed ID: 20824513
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Formulation and in-vitro evaluation of directly compressed controlled release matrices of Losartan Potassium using Ethocel Grade 100 as rate retarding agent.
    Khan KA; Khan GM; Zeeshan Danish M; Akhlaq ; Khan H; Rehman F; Mehsud S
    Int J Pharm; 2015 Dec; 496(2):759-65. PubMed ID: 26545310
    [TBL] [Abstract][Full Text] [Related]  

  • 5. To study the influence of different grades of Ethylcellulose ether derivative polymer Ethocel® and co-excipient on drug release profile of controlled release matrix tablet of acarbose.
    Mehsud S; Rauf M; Obaidullah -; Khan KA; Khan GM
    Pak J Pharm Sci; 2015 Nov; 28(6 Suppl):2259-65. PubMed ID: 26687743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulating drug release behavior and kinetics from matrix tablets based on fine particle-sized ethyl cellulose ether derivatives: an in vitro and in vivo evaluation.
    Shah KU; Khan GM
    ScientificWorldJournal; 2012; 2012():842348. PubMed ID: 22649325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple and rapid approach to evaluate the in vitro in vivo role of release controlling agent ethyl cellulose ether derivative polymer.
    Akhlaq M; Khan GM; Jan SU; Wahab A; Hussain A; Nawaz A; Abdelkader H
    Pak J Pharm Sci; 2014 Nov; 27(6):1789-98. PubMed ID: 25362603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and evaluation of oseltamivir phosphate dual-phase extended-release tablets for the treatment of influenza.
    Yu L; Huang X; Jiang M; Guo W; Li X; Huang F; You J
    Int J Pharm; 2024 Aug; 661():124364. PubMed ID: 38914352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro and in vivo evaluation of hydrophilic and hydrophobic polymers-based nicorandil-loaded peroral tablet compared with its once-daily commercial sustained-release tablet.
    Tamilvanan S; Venkatesh Babu R; Nappinai A; Sivaramakrishnan G
    Drug Dev Ind Pharm; 2011 Apr; 37(4):436-45. PubMed ID: 20923389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation and in vitro evaluation of ofloxacin-ethocel controlled release matrix tablets prepared by wet granulation method: influence of co-excipients on drug release rates.
    Shah S; Shah K; Jan SU; Ahmad K; Rehman A; Hussain A; Khan GM
    Pak J Pharm Sci; 2011 Jul; 24(3):255-61. PubMed ID: 21715257
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations.
    Khan GM; Meidan VM
    Drug Dev Ind Pharm; 2007 Jun; 33(6):627-39. PubMed ID: 17613027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of the controlled-release nisoldipine coat-core tablet formulation.
    Heinig R; Ahr G; Hayauchi Y; Kuhlmann J
    Int J Clin Pharmacol Ther; 1997 Aug; 35(8):341-51. PubMed ID: 9266290
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
    Jan SU; Khan GM; Hussain I
    Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of Floating Delivery for Solid Self Micro-Emulsifying Drug Delivery System of Prochlorperazine Maleate.
    Jagdale S; Shinde M
    Recent Pat Drug Deliv Formul; 2017; 11(3):198-210. PubMed ID: 29119940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. QbD-Oriented Development and Characterization of Effervescent Floating-Bioadhesive Tablets of Cefuroxime Axetil.
    Bansal S; Beg S; Garg B; Asthana A; Asthana GS; Singh B
    AAPS PharmSciTech; 2016 Oct; 17(5):1086-99. PubMed ID: 26527606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastroretentive inorganic-organic hybrids to improve class IV drug absorption.
    Perioli L; Pagano C
    Int J Pharm; 2014 Dec; 477(1-2):21-31. PubMed ID: 25290811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of polymer properties on direct compression and drug release from water-insoluble controlled release matrix tablets.
    Grund J; Koerber M; Walther M; Bodmeier R
    Int J Pharm; 2014 Jul; 469(1):94-101. PubMed ID: 24746409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns.
    Shah SU; Shah KU; Rehman A; Khan GM
    Pak J Pharm Sci; 2011 Apr; 24(2):183-92. PubMed ID: 21454168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-dose relative bioavailability of a new quetiapine fumarate extended-release formulation: a postprandial, randomized, open-label, two-period crossover study in healthy Uruguayan volunteers.
    Estevez-Carrizo FE; Parrillo S; Ercoli MC; Estevez-Parrillo FT
    Clin Ther; 2011 Jun; 33(6):738-45. PubMed ID: 21704238
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preparation and evaluation of once-daily sustained-release coated tablets of tolterodine-L-tartrate.
    Pradhan R; Kim YI; Chang SW; Kim JO
    Int J Pharm; 2014 Jan; 460(1-2):205-11. PubMed ID: 24184032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.